Best Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.
Industry: Biotechnology
F
Biotech is Zen Rated F and is the 135th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.34B | N/A | -1.90% | 32.23% | 8.40% | -2.15 | 1.87 | 97.40% | -1.50% | 13.77% | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $10.06B | -9.30% | -3.20% | -5.54% | -7.00% | 1.87 | 1.65 | 88.50% | -8.90% | -12.10% | ||
| PHAR | PHARMING GROUP NV | $1.09B | 0.20% | 0.10% | 3.90% | 5.60% | 0.79 | 3.16 | 89.90% | 0.10% | 4.15% | ||
| MDXG | MIMEDX GROUP INC | $762.73M | 19.20% | 14.30% | 20.39% | 49.90% | 0.34 | 4.41 | 82.00% | 10.40% | 13.54% | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.90B | 21.80% | 14.90% | 18.63% | 18.80% | 0.44 | 5.76 | 88.90% | 29.30% | 31.63% | ||
| MIRM | MIRUM PHARMACEUTICALS INC | $5.16B | -16.50% | -5.80% | -4.24% | -6.30% | 1.69 | 3.31 | 79.90% | -8.80% | -5.61% | ||
| INVA | INNOVIVA INC | $1.63B | 16.60% | 9.60% | 12.65% | 18.40% | 0.42 | 14.12 | 81.50% | 32.80% | 44.95% | ||
| EXEL | EXELIXIS INC | $11.77B | 31.60% | 24.00% | 35.65% | 37.50% | 0.31 | 3.75 | 96.60% | 29.60% | 38.16% | ||
| VCYT | VERACYTE INC | $2.86B | 2.50% | 2.30% | 2.39% | 15.10% | 0.09 | 6.23 | 68.50% | 6.10% | 6.26% | ||
| TVTX | TRAVERE THERAPEUTICS INC | $2.66B | -178.70% | -15.80% | -19.15% | -13.30% | 6.32 | 2.75 | 97.60% | -20.30% | -17.73% | ||
| HALO | HALOZYME THERAPEUTICS INC | $9.55B | 141.60% | 27.90% | 55.18% | 32.60% | 3.41 | 1.59 | 84.50% | 47.90% | 61.45% | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $43.35B | 26.10% | 1.00% | 3.95% | 2.60% | 19.74 | 2.54 | 83.90% | 1.40% | 4.06% | ||
| INCY | INCYTE CORP | $21.28B | 29.80% | 20.40% | 31.86% | 76.00% | 0.36 | 3.20 | 92.90% | 24.70% | 33.05% | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $3.35B | -29.70% | -12.50% | -10.57% | -9.70% | 1.35 | 3.50 | 90.00% | -13.90% | -9.02% | ||
| ONC | BEONE MEDICINES LTD | $39.20B | 1.90% | 1.10% | 3.08% | 6.60% | 0.85 | 2.39 | 86.20% | 1.40% | 3.26% | ||
| RPRX | ROYALTY PHARMA PLC | $25.77B | 7.80% | 4.20% | 5.55% | 4.30% | 1.01 | 3.48 | 100.00% | 32.60% | 44.44% | ||
| TBPH | THERAVANCE BIOPHARMA INC | $1.04B | 14.70% | 7.60% | 13.16% | 20.60% | 0.79 | 9.48 | 100.00% | 36.50% | 61.95% | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $121.26B | 21.80% | 15.60% | 21.88% | 30.10% | 0.44 | 2.36 | 86.30% | 31.30% | 38.06% | ||
| APLS | APELLIS PHARMACEUTICALS INC | $2.97B | 18.90% | 5.00% | 11.77% | 12.30% | 1.64 | 3.54 | 88.80% | 4.40% | 9.02% | ||
| NAGE | NIAGEN BIOSCIENCE INC | $414.99M | 34.60% | 24.10% | 28.18% | 203.70% | 0.39 | 4.12 | 63.90% | 16.40% | 17.04% | ||
| IDYA | IDEAYA BIOSCIENCES INC | $2.82B | -15.50% | -14.40% | -14.34% | -17.40% | 0.09 | 12.44 | 100.00% | -74.80% | -74.82% | ||
| FENC | FENNEC PHARMACEUTICALS INC | $220.44M | N/A | -15.00% | -9.73% | -11.40% | -11.97 | 4.69 | 93.10% | -17.90% | -9.89% | ||
| RIGL | RIGEL PHARMACEUTICALS INC | $619.87M | 204.70% | 57.40% | 82.30% | 118.40% | 1.06 | 2.28 | 93.10% | 40.20% | 43.22% | ||
| GYRE | GYRE THERAPEUTICS INC | $759.11M | 8.20% | 4.70% | 7.05% | 10.60% | 0.22 | 6.20 | 95.50% | 6.20% | 9.43% | ||
| VCEL | VERICEL CORP | $1.83B | 4.30% | 3.00% | 3.40% | 3.50% | 0.41 | 4.87 | 73.80% | 5.10% | 5.35% | ||
| TGTX | TG THERAPEUTICS INC | $4.58B | 133.20% | 60.40% | 13.25% | 16.00% | 0.69 | 3.83 | 85.30% | 84.10% | 21.62% | ||
| SEPN | SEPTERNA INC | $1.14B | -14.80% | -12.30% | -11.10% | -25.20% | 0.56 | 6.53 | 100.00% | -266.80% | -267.49% | ||
| ANAB | ANAPTYSBIO INC | $1.38B | -1,101.20% | -21.20% | -26.84% | -13.70% | -13.00 | 8.68 | 100.00% | -49.90% | -49.89% | ||
| AKBA | AKEBIA THERAPEUTICS INC | $368.86M | -137.70% | -5.10% | 4.74% | 14.70% | 7.76 | 1.94 | 79.00% | -7.10% | 4.86% | ||
| MNKD | MANNKIND CORP | $1.77B | -49.30% | 6.80% | 16.19% | 11.30% | -12.10 | 3.29 | 75.20% | 9.30% | 19.89% | ||
| TARS | TARSUS PHARMACEUTICALS INC | $2.74B | -26.30% | -17.00% | -17.27% | -22.00% | 0.60 | 4.29 | 93.30% | -22.20% | -19.70% | ||
| LGND | LIGAND PHARMACEUTICALS INC | $3.75B | 5.70% | 4.50% | 4.62% | 9.50% | 0.55 | 24.69 | 94.30% | 19.30% | 26.59% | ||
| FBIO | FORTRESS BIOTECH INC | $101.49M | -14.70% | -3.20% | 11.79% | 23.20% | 2.08 | 2.19 | 71.60% | -8.60% | 24.09% | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $484.16M | 42.70% | 16.10% | 25.35% | 37.20% | 1.03 | 8.62 | 80.70% | 41.90% | 73.31% | ||
| PTCT | PTC THERAPEUTICS INC | $6.00B | -182.70% | 31.20% | 49.46% | 100.80% | -17.97 | 2.32 | 96.80% | 42.30% | 49.41% | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.15B | 24.90% | 17.00% | 24.96% | 55.80% | 0.45 | 3.76 | 77.70% | 22.50% | 29.76% | ||
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | $2.41B | -41.00% | -15.60% | -16.66% | -14.60% | 1.40 | 3.38 | 71.80% | -31.50% | -26.84% | ||
| TNGX | TANGO THERAPEUTICS INC | $1.68B | -60.80% | -38.70% | -52.38% | -48.80% | 0.31 | 8.88 | 100.00% | -151.10% | -150.99% | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $349.71M | 36.10% | 18.30% | 32.49% | 61.40% | 0.76 | 1.74 | 76.90% | 17.40% | 18.41% | ||
| FHTX | FOGHORN THERAPEUTICS INC | $321.21M | N/A | -29.60% | -60.16% | -57.40% | -3.29 | 2.16 | 100.00% | -294.20% | -294.16% | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $1.16B | N/A | -4.70% | 5.51% | 4.50% | -430.96 | 1.93 | 84.60% | -5.90% | 5.26% | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.00B | 26.40% | 23.00% | 30.97% | 370.30% | 0.14 | 6.62 | 85.70% | 37.60% | 49.43% | ||
| NBP | NOVABRIDGE BIOSCIENCES | $426.79M | -11.50% | -10.80% | -9.39% | -26.90% | 0.07 | 14.47 | N/A | N/A | N/A | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.27B | 7.50% | 5.60% | 8.26% | 14.10% | 0.33 | 3.85 | 87.50% | 6.00% | 8.13% | ||
| SLNO | SOLENO THERAPEUTICS INC | $2.23B | -25.90% | -19.80% | -13.08% | -25.00% | 0.21 | 16.08 | 98.10% | -79.50% | -75.09% | ||
| SPRO | SPERO THERAPEUTICS INC | $136.34M | -125.90% | -57.60% | -107.47% | -555.50% | 1.05 | 3.83 | 100.00% | -108.10% | -107.39% | ||
| REGN | REGENERON PHARMACEUTICALS INC | $83.04B | 14.80% | 11.50% | 14.57% | 15.60% | 0.30 | 4.13 | 85.40% | 31.40% | 36.77% | ||
| GMAB | GENMAB A | $19.84B | 27.40% | 22.20% | 30.81% | 79.80% | 0.22 | 6.03 | 94.30% | 41.30% | 54.29% | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $3.99B | 32.30% | 21.40% | 28.09% | 51.70% | 0.45 | 3.02 | 91.90% | 24.90% | 26.14% | ||
| VRCA | VERRICA PHARMACEUTICALS INC | $65.58M | N/A | -59.00% | -143.79% | -62.50% | -3.40 | 1.26 | 91.40% | -84.40% | -55.91% | ||
| PRLD | PRELUDE THERAPEUTICS INC | $136.42M | -121.20% | -84.90% | -145.98% | -120.10% | 0.62 | 3.21 | 100.00% | -1,719.60% | -1,719.57% | ||
| IMCR | IMMUNOCORE HOLDINGS PLC | $1.62B | -7.70% | -2.80% | -1.28% | -1.40% | 1.78 | 6.00 | 99.30% | -7.70% | -3.15% | ||
| ARGX | ARGENX SE | $49.53B | 24.70% | 21.40% | 10.88% | 20.20% | 0.18 | 5.60 | -19,733.10% | 78,552.00% | 40,946.87% | ||
| XOMA | XOMA ROYALTY CORP | $307.84M | 20.30% | 7.20% | 10.39% | 12.10% | 1.77 | 3.91 | 100.00% | 35.20% | 51.78% | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.17B | 8.80% | 7.10% | 10.12% | 12.20% | 0.26 | 4.83 | 81.30% | 16.80% | 22.30% | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $128.48M | 17.80% | 13.80% | 15.12% | 20.30% | 0.25 | 8.94 | 100.00% | 30.70% | 30.71% | ||
| BNTX | BIONTECH SE | $25.64B | -3.00% | -2.60% | -2.32% | -5.00% | 0.16 | 7.12 | 82.50% | -18.10% | -14.07% | ||
| KRYS | KRYSTAL BIOTECH INC | $7.91B | 19.40% | 17.60% | 16.27% | 26.80% | 0.09 | 10.14 | 94.30% | 53.30% | 50.10% | ||
| TECH | BIO-TECHNE CORP | $10.45B | 4.10% | 3.20% | 5.15% | 9.40% | 0.25 | 4.54 | 65.20% | 6.70% | 10.09% | ||
| ZYME | ZYMEWORKS INC | $1.70B | -19.20% | -15.00% | -15.78% | -19.20% | 0.24 | 6.94 | 100.00% | -47.20% | -41.69% | ||
| AXSM | AXSOME THERAPEUTICS INC | $9.20B | -357.20% | -37.10% | -72.12% | -135.20% | 8.08 | 1.57 | 91.90% | -40.90% | -39.70% | ||
| LXRX | LEXICON PHARMACEUTICALS INC | $446.98M | -52.90% | -26.70% | -31.71% | -33.80% | 0.71 | 5.64 | 99.40% | -96.80% | -82.43% | ||
| DOMH | DOMINARI HOLDINGS INC | $59.73M | 116.20% | 102.20% | 51.12% | 114.70% | 0.06 | 27.54 | 100.00% | 110.90% | 110.86% | ||
| KROS | KEROS THERAPEUTICS INC | $535.29M | 9.50% | 8.90% | 9.90% | 160.40% | 0.06 | 29.86 | 100.00% | 26.10% | 28.84% | ||
| LQDA | LIQUIDIA CORP | $3.74B | -296.80% | -49.20% | -57.91% | -60.30% | 11.52 | 2.20 | 89.10% | -176.00% | -144.78% | ||
| VRDN | VIRIDIAN THERAPEUTICS INC | $2.79B | -52.60% | -47.10% | -56.88% | -61.20% | 0.15 | 11.28 | 100.00% | -426.60% | -423.02% | ||
| FTRE | FORTREA HOLDINGS INC | $1.35B | -119.70% | -33.10% | -50.31% | -67.10% | 3.72 | 1.00 | 18.60% | -36.80% | -33.32% | ||
| UTHR | UNITED THERAPEUTICS CORP | $20.90B | 18.80% | 16.80% | 24.85% | 31.70% | 0.12 | 6.40 | 88.60% | 40.70% | 54.04% | ||
| NBTX | NANOBIOTIX SA | $1.01B | N/A | -78.30% | 217.34% | -442.80% | -1.66 | 0.63 | 100.00% | -508.40% | -382.20% | ||
| EVAX | EVAXION A | $21.22M | -320.20% | -63.60% | -59.92% | -74.40% | 2.61 | 3.42 | 100.00% | -377.00% | -323.11% | ||
| CORT | CORCEPT THERAPEUTICS INC | $4.29B | 15.90% | 12.60% | 9.84% | 11.20% | 0.30 | 3.14 | 98.20% | 14.10% | 8.65% | ||
| STTK | SHATTUCK LABS INC | $238.57M | -73.80% | -66.00% | -57.79% | -212.60% | 0.08 | 17.00 | 100.00% | -5,489.50% | -5,489.50% | ||
| CRMD | CORMEDIX INC | $605.89M | 81.80% | 51.10% | 17.50% | 93.70% | 1.01 | 1.94 | 92.60% | 75.80% | 50.40% | ||
| CTXR | CITIUS PHARMACEUTICALS INC | $15.68M | -57.90% | -29.90% | -41.98% | -54.50% | 0.79 | 0.62 | N/A | N/A | N/A | ||
| SABS | SAB BIOTHERAPEUTICS INC | $198.52M | 33.40% | 25.30% | 11.00% | 32.60% | 0.11 | 10.50 | 100.00% | 16,338.30% | 16,554.61% | ||
| ASMB | ASSEMBLY BIOSCIENCES INC | $414.73M | -59.00% | -28.60% | -20.70% | -62.50% | 0.31 | 4.44 | N/A | N/A | N/A | ||
| CGON | CG ONCOLOGY INC | $4.06B | -21.70% | -20.80% | -21.66% | -24.80% | 0.06 | 22.79 | 27.50% | -6,968.00% | -6,967.99% | ||
| ORMP | ORAMED PHARMACEUTICALS INC | $135.73M | 27.20% | 25.60% | 20.05% | 36.60% | 0.09 | 22.25 | 0.60% | 2,192.60% | 2,149.00% | ||
| MESO | MESOBLAST LTD | $2.04B | -19.00% | -14.10% | -11.56% | -103.10% | 0.31 | 1.99 | 70.20% | -593.90% | -458.45% | ||
| ADMA | ADMA BIOLOGICS INC | $3.91B | 54.00% | 39.40% | 32.05% | 35.70% | 0.32 | 7.13 | 54.70% | 42.90% | 33.60% | ||
| PTN | PALATIN TECHNOLOGIES INC | $26.77M | N/A | -96.50% | -1,209.66% | 77.40% | 20.73 | 1.02 | 100.00% | -54.30% | -54.20% | ||
| PYPD | POLYPID LTD | $70.76M | -312.80% | -120.70% | -134.93% | -203.00% | 0.84 | 2.28 | N/A | N/A | N/A | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $9.03B | 36.10% | 13.60% | 24.97% | 17.70% | 1.83 | 3.38 | 100.00% | 18.50% | 28.77% | ||
| ENTA | ENANTA PHARMACEUTICALS INC | $389.93M | -93.80% | -26.10% | -32.68% | -28.20% | 3.34 | 4.21 | 100.00% | -125.40% | -116.14% | ||
| IBRX | IMMUNITYBIO INC | $5.96B | N/A | -86.70% | -48.87% | -21.30% | -1.99 | 5.77 | 99.60% | -422.30% | -273.40% | ||
| ARDX | ARDELYX INC | $1.78B | -36.90% | -12.60% | -9.25% | -7.50% | 2.15 | 4.41 | 88.20% | -14.20% | -9.35% | ||
| INBX | INHIBRX BIOSCIENCES INC | $1.22B | -186.10% | -76.30% | -103.24% | -213.90% | 3.82 | 4.49 | 100.00% | -11,077.60% | -10,433.79% | ||
| AGEN | AGENUS INC | $99.98M | N/A | -16.70% | -46.53% | 346.20% | -1.88 | 0.47 | 98.90% | -33.10% | 23.19% | ||
| CLLS | CELLECTIS SA | $258.20M | -31.80% | -9.80% | -4.50% | -4.00% | 2.41 | 1.49 | 100.00% | -42.80% | -10.61% | ||
| NTHI | NEONC TECHNOLOGIES HOLDINGS INC | $190.26M | N/A | N/A | N/A | N/A | -1.35 | 0.19 | N/A | N/A | N/A | ||
| ALDX | ALDEYRA THERAPEUTICS INC | $332.70M | -72.20% | -47.90% | -83.73% | -130.90% | 0.58 | 2.72 | N/A | N/A | N/A | ||
| LYEL | LYELL IMMUNOPHARMA INC | $481.87M | -96.70% | -76.00% | -86.59% | -101.30% | 0.24 | 10.30 | 100.00% | -957,823.50% | -957,823.53% | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $232.42M | 11.30% | 7.00% | 12.37% | 18.00% | 0.56 | 3.03 | 57.50% | 8.70% | 12.06% | ||
| PHAT | PHATHOM PHARMACEUTICALS INC | $894.92M | N/A | -94.40% | -138.80% | -37.00% | -1.57 | 2.23 | 87.20% | -186.50% | -138.77% | ||
| SLN | SILENCE THERAPEUTICS PLC | $224.14M | N/A | -38.10% | -52.83% | -97.50% | -0.98 | 7.69 | 90.50% | -255.10% | -261.96% | ||
| ERAS | ERASCA INC | $3.49B | -33.10% | -27.80% | -32.60% | -31.00% | 0.21 | 10.45 | N/A | N/A | N/A | ||
| ASND | ASCENDIS PHARMA A | $13.57B | N/A | -20.80% | -11.41% | -2.80% | -7.63 | 1.03 | 86.80% | -36.00% | -2.97% | ||
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | $1.17B | -32.10% | -28.20% | -31.77% | -35.90% | 0.14 | 8.68 | 89.40% | -113.50% | -108.69% | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | $143.78M | -184.40% | -95.50% | -89.14% | 368.10% | 0.35 | 3.83 | N/A | N/A | N/A | ||
| UPB | UPSTREAM BIO INC | $1.42B | -28.80% | -28.10% | -32.23% | -40.80% | 0.03 | 32.67 | 100.00% | -4,386.40% | -4,366.77% |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.